The new GLP1 is produced by drug maker Eli Lilly, designed to be taken once a day to treat obesity and adults
Semaglutide targets the GLP-1 receptor only
Health Canada added that it is currently reviewing eight other submissions for generic semaglutide by different companies and expects to make additional regulatory decisions in the coming weeks and months. The regulator said its review ensures that differences between the generic products and the reference biologic do not affect the safety, efficacy, or quality of the drug. It added that the availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for patients and the healthcare system, and that many generic medicines in Canada are 45% to 90% cheaper than their brandname counterparts
Additional freight charges apply to this item, most of which are included in the item price
Likewise, the study from Diabetes Epidemiology and Management saw a mean reduction in body mass index (BMI) of 13% at six months and 19.7% at 12 months
Patients should be instructed on how to properly inject tirzepatide, including the best injection sites and techniques to minimize discomfort and ensure effective absorption